Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

BioMedPartners (Group)

Based in Basel, Switzerland, BioMedPartners is an independent European venture capital firm that acts as lead-or co-lead investor providing private equity to early-to mid-stage life sciences companies. Since 2002, BioMedPartners has invested in several highly innovative companies of which twenty-two have already either successfully been acquired by leading biopharma companies or have completed an IPO. With more than CHF 350 million in capital under management and a strong team of experienced industry experts as well as an extensive scientific and pharma network, BioMedPartners has established itself as one of the leading early-stage human healthcare investors in Europe. In February 2018, the company announced the closing of BioMedInvest III, their third equity venture capital fund of CHF 100 million. In this third fund BioMedPartners is focusing on the build-up of companies with highly innovative early stage assets and technology platforms. The first investment of BioMedInvest III was in the Swiss immuno-oncology company Amal SA (Geneva) which has been acquired by Boehringer Ingelheim in June 2019. *


Period Start 2009-03-13 renamed
  Predecessor BioMedInvestor (Group)
Products Industry venture capital
  Industry 2 BIOTECH
Persons Person Hosang, Markus (BioMedPartners 201108 General Partner)
  Person 2 Fischer, Karsten (Memo Therapeutics 201806– CEO before BioMedPartners + WestLB)
Region Region Basel BS
  Country Switzerland
  Street 23 Elisabethenstr.
  City 4051 Basel BS
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency CHF
  Annual sales 350,000,000 (capital under management 2020-10-19)
    * Document for �About Section�: Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing". Hamburg.
Record changed: 2021-04-05


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for BioMedPartners (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top